Alakuş, H. Et Al. 2023. Nuclear factor erythroid-2-related factor 2 (Nrf2) is a potential prognostic factor in patients with gastric adenocarcinoma. Arab Journal of Gastroenterology , vol.24, no.1 , 5-10.

Alakuş, H., Kaya, M., ÖZER, H., EĞİLMEZ, H. R., & KARADAYI, K., (2023). Nuclear factor erythroid-2-related factor 2 (Nrf2) is a potential prognostic factor in patients with gastric adenocarcinoma. Arab Journal of Gastroenterology , vol.24, no.1, 5-10.

Alakuş, Hüseyin Et Al. "Nuclear factor erythroid-2-related factor 2 (Nrf2) is a potential prognostic factor in patients with gastric adenocarcinoma," Arab Journal of Gastroenterology , vol.24, no.1, 5-10, 2023

Alakuş, Hüseyin Et Al. "Nuclear factor erythroid-2-related factor 2 (Nrf2) is a potential prognostic factor in patients with gastric adenocarcinoma." Arab Journal of Gastroenterology , vol.24, no.1, pp.5-10, 2023

Alakuş, H. Et Al. (2023) . "Nuclear factor erythroid-2-related factor 2 (Nrf2) is a potential prognostic factor in patients with gastric adenocarcinoma." Arab Journal of Gastroenterology , vol.24, no.1, pp.5-10.

@article{article, author={Hüseyin Alakuş Et Al. }, title={Nuclear factor erythroid-2-related factor 2 (Nrf2) is a potential prognostic factor in patients with gastric adenocarcinoma}, journal={Arab Journal of Gastroenterology}, year=2023, pages={5-10} }